Scribe Therapeutics
SCTX18.97012.38% ( -2.680 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Scribe Therapeutics(SCTX) the Revenue is 2.233 M (-86.96%);the EBIT is -12.43 M (-123.6%);the EPS is -7.05 (-397.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B86.96%
----
----
EBIT
-0.01B123.63%
----
----
EPS
-7.0493397.57%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf